Use of Guideline-Recommended Heart Failure Drugs in High-, Middle-, and Low-Income Countries: A Systematic Review and Meta-Analysis
References
- Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, et al. The global health and economic burden of hospitalizations for heart failure: Lessons learned from hospitalized heart failure registries. Journal of the American College of Cardiology. 2014; 63(12):1123–1133. DOI: 10.1016/j.jacc.2013.11.053
- Callender T, Woodward M, Roth G, Farzadfar F, Lemarie JC, Gicquel S, et al. Heart failure care in low- and middle-income countries: A systematic review and meta-analysis. PLoS Medicine. 2014; 11(8):
e1001699 . DOI: 10.1371/journal.pmed.1001699 - Bragazzi NL, Zhong W, Shu J, Abu Much A, Lotan D, Grupper A, et al. Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017. European Journal of Preventive Cardiology. 2021; 28(15):1682–1690. DOI: 10.1093/eurjpc/zwaa147
- McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal. 2021; 42(36):3599–3726. DOI: 10.1093/eurheartj/ehab368
- Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022; 145(18):e895–e1032. DOI: 10.1161/CIR.0000000000001073
- Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics-2020 update: A report from the American Heart Association. Circulation. 2020; 141(9):e139–e596.
- Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Journal of Heart Failure. 2016; 18(8):891–975. DOI: 10.1002/ejhf.592
- Dokainish H, Teo K, Zhu J, Roy A, AlHabib KF, ElSayed A, et al. Global mortality variations in patients with heart failure: Results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study. The Lancet Global Health. 2017; 5(7):e665–e672.
- Tromp J, Bamadhaj S, Cleland JGF, Angermann CE, Dahlstrom U, Ouwerkerk W, et al. Correction to: Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): A cohort study. The Lancet Global Health. 2020; 8(8):
e1001 . DOI: 10.1016/S2214-109X(20)30294-1 - Tromp J, Bamadhaj S, Cleland JGF, Angermann CE, Dahlstrom U, Ouwerkerk W, et al. Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): A cohort study. The Lancet Global Health. 2020; 8(3):e411–e422. DOI: 10.1016/S2214-109X(20)30004-8
- Ferreira JP, Kraus S, Mitchell S, Perel P, Pineiro D, Chioncel O, et al. World Heart Federation roadmap for heart failure. Global Heart. 2019; 14(3):197–214. DOI: 10.1016/j.gheart.2019.07.004
- Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Colvin MM, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017; 136(6):e137–e161. DOI: 10.1161/CIR.0000000000000509
- Thorvaldsen T, Benson L, Dahlstrom U, Edner M, Lund LH. Use of evidence-based therapy and survival in heart failure in Sweden 2003–2012. European Journal of Heart Failure. 2016; 18(5):503–511. DOI: 10.1002/ejhf.496
- Crespo-Leiro MG, Anker SD, Maggioni AP, Coats AJ, Filippatos G, Ruschitzka F, et al. European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions. European Journal of Heart Failure. 2016; 18(6):613–625. DOI: 10.1002/ejhf.566
- Patel DB, Shah RM, Bhatt DL, Liang L, Schulte PJ, DeVore AD, et al. Guideline-appropriate care and in-hospital outcomes in patients with heart failure in teaching and nonteaching hospitals: Findings from get with the guidelines-heart failure. Circulation: Cardiovascular Quality and Outcomes. 2016; 9(6):757–766. DOI: 10.1161/CIRCOUTCOMES.115.002542
- Sandhu AT, Kohsaka S, Turakhia MP, Lewis EF, Heidenreich PA. Evaluation of quality of care for US veterans with recent-onset heart failure with reduced ejection fraction. JAMA Cardiology. 2022; 7(2):130–139. DOI: 10.1001/jamacardio.2021.4585
- Chang HY, Wang CC, Wei J, Chang CY, Chuang YC, Huang CL, et al. Gap between guidelines and clinical practice in heart failure with reduced ejection fraction: Results from TSOC-HFrEF registry. Journal of Chinese Medical Association. 2017; 80(12):750–757. DOI: 10.1016/j.jcma.2017.04.011
- Jarjour M, Henri C, de Denus S, Fortier A, Bouabdallaoui N, Nigam A, O’Meara E, Ahnadi C, White M, et al. Care gaps in adherence to heart failure guidelines: Clinical inertia or physiological limitations? JACC Heart Failure. 2020; 8(9):725–738. DOI: 10.1016/j.jchf.2020.04.019
- Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Journal of Clinical Epidemiology. 2021; 134:178–189. DOI: 10.1016/j.jclinepi.2021.03.001
- Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2016; 37(27):2129–2200. DOI: 10.1093/eurheartj/ehw128
- Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine. 2002; 21(11):1539–1558. DOI: 10.1002/sim.1186
- World Bank Blogs. New World Bank country classifications by income level: 2021–2022; 2021. Available from:
https://blogs.worldbank.org/opendata/new-world-bank-country-classifications-income-level-2021-2022 [Accessed 15 Feb 2022]. - World Health Organization Countries.
https://www.who.int/countries [Accessed 15 Feb 2022]. - Hebert K, Kaif M, Tamariz L, Gogichaishvili I, Nozadze N, Delgado MC, et al. Prevalence of stroke in systolic heart failure. Journal of Cardiac Failure. 2011; 17(1):76–81. DOI: 10.1016/j.cardfail.2010.08.008
- Frohlich H, Nelges C, Tager T, Schwenger V, Cebola R, Schnorbach J, et al. Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease. American Heart Journal. 2016; 178:28–36. DOI: 10.1016/j.ahj.2016.03.024
- Tromp J, Ouwerkerk W, Teng TK, Cleland JGF, Bamadhaj S, Angermann CE, et al. Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction. European Heart Journal. 2022; 43(23):2224–2234. DOI: 10.1093/eurheartj/ehac103
- Walli-Attaei M, Joseph P, Johansson I, et al. Characteristics, management, and outcomes in women and men with congestive heart failure in 40 countries at different economic levels: An analysis from the Global Congestive Heart Failure (G-CHF) registry. The Lancet Global Health. 2024; 12(3):e396–e405. DOI: 10.1016/S2214-109X(23)00557-0
- Johansson I, Joseph P, Balasubramanian K, McMurray L, Ezekowitz K, Alhabib B, et al. Health-related quality of life and mortality in heart failure: The Global Congestive Heart Failure Study of 23,000 patients from 40 countries. Circulation. 2021; 143(22):2129–2142. DOI: 10.1161/CIRCULATIONAHA.120.050850
- Dokainish H, Teo K, Zhu J, Roy A, AlHabib KF, ElSayed A, et al. Heart failure in Africa, Asia, the Middle East and South America: The INTER-CHF study. International Journal of Cardiology. 2016; 204:133–141. DOI: 10.1016/j.ijcard.2015.11.183
- Teng TK, Tromp J, Tay WT, Anand I, Ouwerkerk W, Chopra V, et al. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: A cohort study. The Lancet Global Health. 2018; 6(9):e1008–e1018. DOI: 10.1016/S2214-109X(18)30306-1
- Lombardi CM, Ferreira JP, Carubelli V, Anker SD, Cleland JG, Dickstein K, et al. Geographical differences in heart failure characteristics and treatment across Europe: results from the BIOSTAT-CHF study. Clinical Research in Cardiology. 2020;109(8):967–977. DOI: 10.1007/s00392-019-01588-7
- Gómez-Mesa JE, Gutiérrez-Posso JM, Escalante-Forero M, et al. American Registry of Ambulatory or acutely decompensated heart failure (AMERICCAASS Registry): First 1000 patients. Clinical Cardiology. 2024; 47(2):
e24182 . DOI: 10.1002/ehf2.14965 - Dzudie A, Hongieh Abanda M, Nkoke C, et al. Clinical characteristics and outcomes of black African heart failure patients with preserved, mid-range, and reduced ejection fraction: A post hoc analysis of the THESUS-HF registry. ESC Heart Failure. 2020; 8(1):238–249. DOI: 10.1002/ehf2.12903
- Stolfo D, Benson L, Lindberg F, et al. Status and timing of angiotensin receptor-neprilysin inhibitor implementation in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure Registry. European Journal of Heart Failure. 2024. DOI: 10.1002/ejhf.3404
- Joseph S, Panniyammakal J, Abdullakutty J, et al. The Cardiology Society of India-Kerala Acute Heart Failure Registry: Poor adherence to guideline-directed medical therapy. European Heart Journal. 21:
ehab793 . - Agarwal A, Peters SAE, Chandramouli C, Lam CSP, Figtree GA, Arnott C. Guideline-directed medical therapy in females with heart failure with reduced ejection fraction. Current Heart Failure Report. 2021; 18(5):284–289. DOI: 10.1007/s11897-021-00524-z
- Joseph P, Dokainish H, McCready T, Budaj A, Roy A, Ertl G, et al. A multinational registry to study the characteristics and outcomes of heart failure patients: The global congestive heart failure (G-CHF) registry. American Heart Journal. 2020; 227:56–63. DOI: 10.1016/j.ahj.2020.06.002
- Huffman MD, Roth GA, Sliwa K, et al.
Heart failure . In Prabhakaran D, Anand S, Gaziano TA, et al., (Eds.) Cardiovascular, respiratory, and related disorders, 3rd edn. Washington, DC: The International Bank for Reconstruction and Development/The World Bank; 2017 Nov 17. Chapter 10. Available from:https://www.ncbi.nlm.nih.gov/books/NBK525153/ - Agarwal A, Husain MJ, Datta B, Kishore SP, Huffman MD. Access to heart failure medicines in low- and middle-income countries: An analysis of essential medicines lists, availability, price, and affordability. Circulation: Heart Failure. 2022; 15(4):
e008971 . DOI: 10.1161/CIRCHEARTFAILURE.121.008971 - Salam A, Satheesh G. Enhancing heart failure care in India: The critical role of generic drugs and regulatory reforms. Heart Failure Journal of India. 2024; 2(1):21–22.
- Fonarow GC, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, et al. Improving evidence-based care for heart failure in outpatient cardiology practices: Primary results of the registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Circulation. 2010; 122(6):585–596. DOI: 10.1161/CIRCULATIONAHA.109.934471
DOI: https://doi.org/10.5334/gh.1355 | Journal eISSN: 2211-8179
Language: English
Submitted on: Mar 27, 2024
Accepted on: Aug 27, 2024
Published on: Sep 12, 2024
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
© 2024 Gautam Satheesh, Rupasvi Dhurjati, Laura Alston, Fisaha Tesfay, Rashmi Pant, Ehete Bahiru, Claudia Bambs, Anubha Agarwal, Sanne A. E. Peters, Abdul Salam, Isabelle Johansson, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.